Long‐term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes
Catheterization and Cardiovascular Interventions · 2024
DOI: 10.1002/ccd.30937 ↗At a glance
Randomisierte kontrollierte Studie in Catheterization and Cardiovascular Interventions, 2024. Written by Manijeh Noori and 14 co-authors. Institution: Department of Cardiology, Odense University Hospital, Odense, Denmark. Major MEDLINE topics: Coronary Artery Disease, Acute Coronary Syndrome, Drug-Eluting Stents, Cardiovascular Agents. Cited 2 times so far (Crossref); 33 references. Funded by: Terumo, Tokyo, Japan, Biotronik, Bülach, Switzerland.
Abstract (original language)
Background
Patients with acute coronary syndromes (ACS) may have worse outcomes after percutaneous coronary intervention compared to patients without ACS.
Aims
To compare 5‐year efficacy and safety outcomes in patients with and without ACS treated with biodegradable polymers, the ultrathin strut sirolimus‐eluting Orsiro stent (O‐SES) or the biolimus‐eluting Nobori stent (N‐BES).
Methods
The Scandinavian Organisation for Randomized Trials with Clinical Outcome VII is a randomized trial comparing O‐SES and N‐BES in an all‐comer setting. Of 2525 patients, 1329 (53%) patients had ACS and 1196 (47%) patients were without ACS. Endpoints were target lesion failure (TLF) (a composite of cardiac death, target lesion myocardial infarction, or target lesion revascularization) and definite stent thrombosis within 5 years.
Results
At 5‐year follow‐up, TLF did not differ significantly between patients with and without ACS (12.3% vs. 13.2%; rate ratio (RR) 1.00; 95% confidence interval (CI): 0.70–1.44), whereas the risk of definite stent thrombosis was increased in patients with ACS (2.3% vs. 1.3; RR: 2.01 [95% CI: 1.01–3.98]). In patients with ACS, the rate of TLF was similar between O‐SES and N‐BES (12.4% vs. 12.3%; RR: 1.02; 95% CI: 0.74–1.40). The reduced risk of definite stent thrombosis in O‐SES treated ACS patients within the first year (0.2% vs. 1.6%; RR: 0.12; 95% CI: 0.02–0.93) was not maintained after 5 years (1.8% vs. 2.7%; RR: 0.77; 95% CI: 0.37–1.63).
Conclusion
Patients with ACS had an increased risk of stent thrombosis regardless of the stent type used. Long‐term outcomes were similar for ACS patients treated with O‐SES or N‐BES at 5 years.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cardiology, Odense University Hospital, Odense, Denmark.
- Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
- Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
ORCID profiles: Manijeh Noori
Funding
- Terumo, Tokyo, Japan
- Biotronik, Bülach, Switzerland
Cite
APA
Noori, M., Christiansen, E. H., Raungaard, B., Junker, A., Christensen, M. K., Kahlert, J., Maeng, M., Freeman, P., Hansen, K. N., Terkelsen, C. J., Ellert-Gregersen, J., Kristensen, S. D., Veien, K. T., Jakobsen, L., & Jensen, L. O. (2024). Long‐term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30937
Vancouver
Noori M, Christiansen EH, Raungaard B, Junker A, Christensen MK, Kahlert J, et al. Long‐term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.30937
BibTeX
@article{Noori2024,
author = {Noori, Manijeh and Christiansen, Evald Høj and Raungaard, Bent and Junker, Anders and Christensen, Martin Kirk and Kahlert, Johnny and Maeng, Michael and Freeman, Phillip and Hansen, Kirstine Nørregaard and Terkelsen, Christian Juhl and Ellert-Gregersen, Julia and Kristensen, Steen Dalby and Veien, Karsten Tange and Jakobsen, Lars and Jensen, Lisette Okkels},
title = {Long‐term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
doi = {10.1002/ccd.30937}
}
EUVIMED